|
26 Mar 2020 |
Inzomelid completes Phase I studies and shows positive results in the treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)
|
|
26 Mar 2020 |
Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset
|
|
26 Mar 2020 |
Forge Enters Into Collaboration With Roche To Develop Novel Antibiotic To Treat Lung Infections
|
|
26 Mar 2020 |
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis
|
|
26 Mar 2020 |
Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-Licensing Agreement of 3B Pharmaceutical's Targeted CAIX Radiotherapy
|
|
26 Mar 2020 |
Medicenna's IL-2 Superkine, MDNA19, Demonstrates Best-in-Class Features in a Non-Human Primate Study
|
|
26 Mar 2020 |
Eisai submits marketing authorization application in Japan for anticancer agent denileukin diftitox (genetic recombinant) for cutaneous T-cell lymphoma and peripheral T-cell lymphoma
|
|
26 Mar 2020 |
Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
|
|
26 Mar 2020 |
Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
|
|
26 Mar 2020 |
Xencor and Vir Biotechnology Enter License Agreement for Use of Xtend XmAb Antibody Technology in Investigational Antibodies to Treat COVID-19
|
|
26 Mar 2020 |
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
|
|
25 Mar 2020 |
Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
|
|
25 Mar 2020 |
TEPMETKO® (Tepotinib) Approved in Japan for Advanced NSCLC with METex14 Skipping Alterations
|
|
25 Mar 2020 |
ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic Breast Cancer
|
|
25 Mar 2020 |
AstraZeneca to discover and develop siRNA therapeutics for Cardiovascular, Renal, Metabolic and Respiratory diseases in new collaboration
|
|
25 Mar 2020 |
Allakos Announces the Initiation of Antolimab (AK002) Clinical Studies
|
|
25 Mar 2020 |
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
|
|
24 Mar 2020 |
Aravive Announces Initiation of Investigator-Sponsored Phase 1/2 Study of AVB-500 in Combination with Avelumab in Patients with Advanced Urothelial Carcinoma (COAXIN)
|
|
24 Mar 2020 |
Sorrento collaborates with Mabpharm on development and commercialization of ACE-MAB™ to potentially treat COVID-19
|
|
24 Mar 2020 |
MaxCyte and Allogene Therapeutics Sign Clinical and Commercial License Agreement to Enable the Advancement of Allogeneic CAR T (AlloCAR T™) Therapies
|
